Impact of Molybdenum Compounds as Anticancer Agents
Joint Authors
Mbese, Johannes Z.
Odularu, Ayodele T.
Ajibade, Peter A.
Source
Bioinorganic Chemistry and Applications
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-09-10
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
The aim of this mini review was to report the molybdenum compound intervention to control cancer disease.
The intervention explains its roles and progress from inorganic molybdenum compounds via organomolybdenum complexes to its nanoparticles to control oesophageal cancer and breast cancer as case studies.
Main contributions of molybdenum compounds as anticancer agents could be observed in their nanofibrous support with suitable physicochemical properties, combination therapy, and biosensors (biomarkers).
Recent areas in anticancer drug design, which entail the uses of selected targets, were also surveyed and proposed.
American Psychological Association (APA)
Odularu, Ayodele T.& Ajibade, Peter A.& Mbese, Johannes Z.. 2019. Impact of Molybdenum Compounds as Anticancer Agents. Bioinorganic Chemistry and Applications،Vol. 2019, no. 2019, pp.1-9.
https://search.emarefa.net/detail/BIM-1122466
Modern Language Association (MLA)
Odularu, Ayodele T.…[et al.]. Impact of Molybdenum Compounds as Anticancer Agents. Bioinorganic Chemistry and Applications No. 2019 (2019), pp.1-9.
https://search.emarefa.net/detail/BIM-1122466
American Medical Association (AMA)
Odularu, Ayodele T.& Ajibade, Peter A.& Mbese, Johannes Z.. Impact of Molybdenum Compounds as Anticancer Agents. Bioinorganic Chemistry and Applications. 2019. Vol. 2019, no. 2019, pp.1-9.
https://search.emarefa.net/detail/BIM-1122466
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1122466
